| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.005 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.089 | 0.005 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.008 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.094 | 0.008 |